Screener / SEC EDGAR /CIK 0000278166 /Numbers from the XBRL of the 10-Ks
Nasdaq Materials · Mobile Homes

Cavco Industries, Inc. CVCO

Compare with peers Embed
Planned sales, announced before they happen

1 trading plan running, 9 Form 144 notices for $4.5M

10-Q, 10-K and Form 144

What CVCO's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Aug 9, 2024 to Jan 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.

InsiderWhatDateReported in
Seth Schuknecht
Executive Vice President and General Counsel
Adopted 10b5-1 plan Feb 25, 2026 10-K May 22, 2026
What the company wrote
On February 25, 2026, Seth Schuknecht, the Company's Executive Vice President and General Counsel, adopted a programmed plan of transactions intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (the "Schuknecht 10b5-1 Plan"). This plan provides for a first possible trade date of May 27, 2026, and terminates automatically on January 31, 2027, if not before. The aggregate number of shares to potentially be sold pursuant to the Schuknecht 10b5-1 Plan is up to 542 shares of Common Stock.
Lisa Daniels
independent director
Adopted 10b5-1 plan Dec 12, 2025 10-Q Feb 2, 2026
What the company wrote
On December 12, 2025, Lisa Daniels, an independent director, also adopted a programmed plan of transactions intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (the "Daniels 10b5-1 Plan"). This plan was adopted in order to sell-to-cover a number of shares of our Common Stock to satisfy income tax obligations to be incurred by Ms. Daniels in connection with the anticipated vesting of her restricted stock units on July 28, 2026. The Daniels 10b5-1 Plan provides for a first possible trade date of July 30, 2026, and terminates automatically on August 5, 2026. The aggregate number of shares to be sold pursuant to the plan is 30 shares of our Common Stock.
Allison Aden
Chief Financial Officer
Adopted 10b5-1 plan Nov 26, 2025 10-Q Feb 2, 2026
What the company wrote
On November 26, 2025, Allison Aden, the Company's Chief Financial Officer, adopted a programmed plan of transactions intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (the "Aden 10b5-1 Plan"). This plan provides for a first possible trade date of February 25, 2026, and terminates automatically on July 3, 2026, if not before. The aggregate number of shares to potentially be sold pursuant to the Aden 10b5-1 Plan is up to 3,000 shares of Common Stock.
David Greenblatt
director
Ended 10b5-1 plan Mar 5, 2025 10-K May 23, 2025
What the company wrote
On March 5, 2025, David Greenblatt, a director, terminated his previously adopted plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c). This plan was entered into on December 4, 2024, was set to end on April 15, 2025, and provided for the sale of 4,000 shares of our common stock.
Susan Blount
director
Ended 10b5-1 plan Jan 15, 2025 10-K May 23, 2025
What the company wrote
On January 15, 2025, Susan Blount, a director, terminated her previously adopted plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c). This plan was entered into on September 13, 2024, was set to end on January 30, 2025, and provided for the sale of 1,500 shares of our common stock.
Julia Sze
director
Ended 10b5-1 plan Dec 10, 2024 10-Q Jan 31, 2025
What the company wrote
On December 10, 2024, Julia Sze, a director, terminated her previously adopted plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c). This plan was entered into on August 9, 2024, was set to end on December 10, 2024, and provided for the sale of 250 shares of our Common Stock.
David Greenblatt
director
Adopted 10b5-1 plan Dec 4, 2024 10-Q Jan 31, 2025
What the company wrote
On December 4, 2024, David Greenblatt, a director, adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c) (the "Greenblatt 10b5-1 Plan"). This plan provides for a first possible trade date of March 5, 2025, and terminates automatically on April 15, 2025, if not before. The aggregate number of shares to potentially be sold pursuant to the Greenblatt 10b5-1 Plan is up to 4,000 shares of Common Stock.
Susan Blount
independent director
Adopted 10b5-1 plan Sep 13, 2024 10-Q Nov 1, 2024
What the company wrote
On September 13, 2024, Susan Blount, an independent director, also adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1 (the "Blount 10b5-1 Plan"). This plan provides for a first possible trade date of December 13, 2024, and terminates automatically on January 30, 2025. The aggregate number of shares to be sold pursuant to the Blount 10b5-1 Plan is 1,500 shares of Common Stock.
Julia Sze
independent director
Adopted 10b5-1 plan Aug 9, 2024 10-Q Nov 1, 2024
What the company wrote
On August 9, 2024, Julia Sze, an independent director, adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1 (the "Sze 10b5-1 Plan"). This plan was adopted in order to sell-to-cover a number of shares of our Common Stock to satisfy tax withholding obligations in connection with the vesting of Ms. Sze's restricted stock units on July 30, 2024. The Sze 10b5-1 Plan provides for a first possible trade date of November 8, 2024, and terminates automatically on December 10, 2024. The aggregate number of shares to be sold pursuant to the plan is 250 shares of our Common Stock.
Seth Schuknecht
Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary
Adopted 10b5-1 plan – 10-Q Jan 31, 2025
What the company wrote
On December 5, 2024, Seth Schuknecht, Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary also adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c) (the "Schuknecht 10b5-1 Plan"). This plan provides for a first possible trade date of March 6, 2025, and terminates automatically on October 31, 2025, if not before. The aggregate number of shares to potentially be sold pursuant to the Schuknecht 10b5-1 Plan is up to 167 shares of Common Stock.
Show the other 2 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 19, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 10, 2026 BRIAN CIRA
Officer
2,382 $1.6M
Nov 4, 2026 SETH G SCHUKNECHT
Officer
542 $351K
Nov 4, 2026 KERLEY RICHARD A
Director
459 $298K
Aug 17, 2026 BIGBEE PAUL
Officer
342 $208K
Jul 30, 2026 LISA DANIELS
Director
30 $17K
Jun 25, 2026 ALLISON ADEN
Officer
1,473 $901K
Jun 15, 2026 BIGBEE PAUL
Officer
200 $108K
Jun 12, 2026 ALLISON K. ADEN
Officer
1,208 $724K
Jun 8, 2026 KERLEY RICHARD A
Director
500 $281K
Show the other 1 notices

From the Form 144 XML filed with the SEC, since Jun 8, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CVCO/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.